Correlation Between Salesforce and Arcadia Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Arcadia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Arcadia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Arcadia Biosciences, you can compare the effects of market volatilities on Salesforce and Arcadia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Arcadia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Arcadia Biosciences.

Diversification Opportunities for Salesforce and Arcadia Biosciences

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Salesforce and Arcadia is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Arcadia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcadia Biosciences and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Arcadia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcadia Biosciences has no effect on the direction of Salesforce i.e., Salesforce and Arcadia Biosciences go up and down completely randomly.

Pair Corralation between Salesforce and Arcadia Biosciences

Considering the 90-day investment horizon Salesforce is expected to generate 0.28 times more return on investment than Arcadia Biosciences. However, Salesforce is 3.57 times less risky than Arcadia Biosciences. It trades about 0.35 of its potential returns per unit of risk. Arcadia Biosciences is currently generating about -0.33 per unit of risk. If you would invest  29,377  in Salesforce on August 29, 2024 and sell it today you would earn a total of  4,941  from holding Salesforce or generate 16.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Salesforce  vs.  Arcadia Biosciences

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Arcadia Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Salesforce and Arcadia Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Arcadia Biosciences

The main advantage of trading using opposite Salesforce and Arcadia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Arcadia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will offset losses from the drop in Arcadia Biosciences' long position.
The idea behind Salesforce and Arcadia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated